Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Regulatory Filings 2007

Feb 16, 2007

29777_rns_2007-02-20_1c28877e-2529-451f-8254-c8829ba06b04.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

8-K 1 a07-4540_18k.htm 8-K

*UNITED STATES SECURITIES AND EXCHANGE COMMISSION* WASHINGTON, D.C. 20549

*FORM 8-K*

*CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934*

*February 13, 2007 Date of Report (Date of earliest event reported) ABBOTT LABORATORIES* (Exact name of registrant as specified in its charter)

Illinois 1-2189 36-0698440
(State or other
Jurisdiction (Commission File
Number) (I.R.S. Employer
of
Incorporation) Identification
No.)

100 Abbott Park Road Abbott Park, Illinois 60064-6400 (Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (847) 937-6100

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\fc\47161651386_D11265_1726581\4540-1-ba.htm',USER='jmsproofassembler',CD='Feb 16 16:16 2007'

Item 5.02 — Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

Jack M. Greenberg will not be standing for re-election to the Board of Directors at the Company’s 2007 Annual Meeting of Shareholders in light of increased commitments on his time.

*Signatures*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ Thomas C. Freyman
Thomas C. Freyman
Executive Vice President,
Finance and Chief Financial
Officer

2

SEQ.=1,FOLIO='2',FILE='C:\fc\47161651386_D11265_1726581\4540-1-ba.htm',USER='jmsproofassembler',CD='Feb 16 16:16 2007'